Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1960 1
1967 2
1968 2
1969 4
1970 1
1971 1
1972 1
1973 4
1974 2
1975 7
1976 9
1977 7
1978 7
1979 5
1980 3
1981 6
1982 12
1983 13
1984 12
1985 12
1986 14
1987 12
1988 15
1989 32
1990 26
1991 26
1992 23
1993 24
1994 23
1995 41
1996 26
1997 23
1998 25
1999 27
2000 33
2001 42
2002 34
2003 50
2004 46
2005 61
2006 89
2007 79
2008 88
2009 113
2010 113
2011 106
2012 132
2013 177
2014 212
2015 211
2016 240
2017 235
2018 220
2019 281
2020 300
2021 300
2022 316
2023 274
2024 108

Text availability

Article attribute

Article type

Publication date

Search Results

3,822 results

Results by year

Filters applied: . Clear all
Page 1
Optical coherence tomography.
Podoleanu AG. Podoleanu AG. J Microsc. 2012 Sep;247(3):209-19. doi: 10.1111/j.1365-2818.2012.03619.x. Epub 2012 Jun 18. J Microsc. 2012. PMID: 22708800 Free PMC article. Review.
The review provides a concise explanation of principles of operation of different optical coherence tomography methods. A comparative analysis of their advantages and disadvantages is presented in relation to specific applications. The review will assist the reader …
The review provides a concise explanation of principles of operation of different optical coherence tomography methods. A comparative …
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.
Kaye R, Chandra S, Sheth J, Boon CJF, Sivaprasad S, Lotery A. Kaye R, et al. Prog Retin Eye Res. 2020 Nov;79:100865. doi: 10.1016/j.preteyeres.2020.100865. Epub 2020 May 11. Prog Retin Eye Res. 2020. PMID: 32407978 Review.
This review aims to give an overview of the current pathophysiology hypotheses surrounding CSC in addition to future directions in cellular work from human induced pluripotent stem cell derived choroidal endothelial cells from CSC patients. Furthermore, this review will provide t …
This review aims to give an overview of the current pathophysiology hypotheses surrounding CSC in addition to future directions in cellular …
Behcet's disease: epidemiology, clinical manifestations, and diagnosis.
Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, Mohtasham N, Kavosi H, Masoumi M. Davatchi F, et al. Expert Rev Clin Immunol. 2017 Jan;13(1):57-65. doi: 10.1080/1744666X.2016.1205486. Epub 2016 Jul 11. Expert Rev Clin Immunol. 2017. PMID: 27351485 Review.
The aim of this review was to put together different known reports in order to help the reader to better understand the disease, to avoid the frequent misdiagnosis, and to decide the best treatment. ...
The aim of this review was to put together different known reports in order to help the reader to better understand the disease, to a …
Optical Coherence Tomography Angiography in Glaucoma Care.
Chansangpetch S, Lin SC. Chansangpetch S, et al. Curr Eye Res. 2018 Sep;43(9):1067-1082. doi: 10.1080/02713683.2018.1475013. Epub 2018 May 23. Curr Eye Res. 2018. PMID: 29757019 Review.
PURPOSE: To provide the reader with information on the principal techniques of optical coherence tomography angiography (OCTA); the current literature on OCTA reproducibility; its applications to glaucoma detection and monitoring of progression; and the role of OCTA …
PURPOSE: To provide the reader with information on the principal techniques of optical coherence tomography angiography (OCTA) …
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.
Nguyen XT, Moekotte L, Plomp AS, Bergen AA, van Genderen MM, Boon CJF. Nguyen XT, et al. Int J Mol Sci. 2023 Apr 19;24(8):7481. doi: 10.3390/ijms24087481. Int J Mol Sci. 2023. PMID: 37108642 Free PMC article. Review.
Patients with RP experience a wide variety of physical, mental and social-emotional difficulties during their lifetime, of which some require timely intervention. This review aims to familiarize readers with clinical management options that are currently available for pati …
Patients with RP experience a wide variety of physical, mental and social-emotional difficulties during their lifetime, of which some requir …
m6A modification of circSPECC1 suppresses RPE oxidative damage and maintains retinal homeostasis.
Chen X, Wang Y, Wang JN, Cao QC, Sun RX, Zhu HJ, Zhang YR, Ji JD, Liu QH. Chen X, et al. Cell Rep. 2022 Nov 15;41(7):111671. doi: 10.1016/j.celrep.2022.111671. Cell Rep. 2022. PMID: 36384115 Free article.
Mechanically, nuclear export of circSPECC1 transcript depends on its N(6)-methyladenosine (m(6)A) level with YTHDC1 as the reader. CircSPECC1 directly sponges miR-145-5p to block its interaction with CDKN1A. ...
Mechanically, nuclear export of circSPECC1 transcript depends on its N(6)-methyladenosine (m(6)A) level with YTHDC1 as the reader. Ci …
Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change.
Lin F, Chen S, Song Y, Li F, Wang W, Zhao Z, Gao X, Wang P, Jin L, Liu Y, Chen M, Liang X, Yang B, Ning G, Cheng CY, Healey PR, Park KH, Zangwill LM, Aung T, Ohno-Matsui K, Jonas JB, Weinreb RN, Zhang X; Glaucoma Suspects with High Myopia Study Group. Lin F, et al. Ophthalmology. 2022 Jul;129(7):803-812. doi: 10.1016/j.ophtha.2022.03.001. Epub 2022 Mar 12. Ophthalmology. 2022. PMID: 35288144 Free PMC article.
A subset (n = 1000) of the VFs was used to evaluate the interobserver and intraobserver agreement and weighted kappa values of the classification system by 2 trained readers. The prevalence of various VF patterns and their associated factors were determined. ...The interob …
A subset (n = 1000) of the VFs was used to evaluate the interobserver and intraobserver agreement and weighted kappa values of the classific …
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. Kass MA, et al. Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30. doi: 10.1001/archopht.120.6.701. Arch Ophthalmol. 2002. PMID: 12049574 Clinical Trial.
METHODS: A total of 1636 participants with no evidence of glaucomatous damage, aged 40 to 80 years, and with an IOP between 24 mm Hg and 32 mm Hg in one eye and between 21 mm Hg and 32 mm Hg in the other eye were randomized to either observation or treatment with co …
METHODS: A total of 1636 participants with no evidence of glaucomatous damage, aged 40 to 80 years, and with an IOP between 24 mm Hg and 32 …
Optical Issues in Measuring Strabismus.
Irsch K. Irsch K. Middle East Afr J Ophthalmol. 2015 Jul-Sep;22(3):265-70. doi: 10.4103/0974-9233.159691. Middle East Afr J Ophthalmol. 2015. PMID: 26180462 Free PMC article. Review.
Potential errors and complications during examination and treatment of strabismic patients can be reduced by recognition of certain optical issues. This articles reviews basic as well as guiding principles of prism optics and optics of the eye to equip …
Potential errors and complications during examination and treatment of strabismic patients can be reduced by recognition of certain optic …
Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.
Nittala MG, Metlapally R, Ip M, Chakravarthy U, Holz FG, Staurenghi G, Waheed N, Velaga SB, Lindenberg S, Karamat A, Koester J, Ribeiro R, Sadda S. Nittala MG, et al. JAMA Ophthalmol. 2022 Mar 1;140(3):243-249. doi: 10.1001/jamaophthalmol.2021.6067. JAMA Ophthalmol. 2022. PMID: 35113137 Free PMC article. Clinical Trial.
INTERVENTIONS: Intravitreal pegcetacoplan, 15 mg, or sham injection, monthly or every other month for 12 months. MAIN OUTCOMES AND MEASURES: Masked readers analyzed spectral-domain optical coherence tomography scans in regions beyond a perimeter of 500 mum from the …
INTERVENTIONS: Intravitreal pegcetacoplan, 15 mg, or sham injection, monthly or every other month for 12 months. MAIN OUTCOMES AND MEASURES: …
3,822 results